Financial Performance - The company reported a total revenue of 582 million yuan, an increase of 48.89 million yuan compared to the same period last year, representing a year-on-year growth of 9.18% [1] - The net profit attributable to shareholders was -15.75 million yuan [1] - The net cash inflow from operating activities was 12.52 million yuan, an increase of 980,000 yuan compared to the same period last year, reflecting a year-on-year increase of 8.50% [1] Financial Ratios - The latest debt-to-asset ratio is 43.62%, ranking second among disclosed peers, with a decrease of 0.35 percentage points from the previous quarter [3] - The latest gross profit margin is 12.60% [3] - The latest return on equity (ROE) is -1.84% [3] Efficiency Metrics - The diluted earnings per share are -0.04 yuan [4] - The total asset turnover ratio is 0.35 times, an increase of 0.03 times compared to the same period last year, achieving a year-on-year growth of 8.75% [4] - The inventory turnover ratio is 2.55 times, an increase of 0.34 times compared to the same period last year, representing a year-on-year increase of 15.32% [4] Shareholder Information - The number of shareholders is 45,900, with the top ten shareholders holding 194 million shares, accounting for 52.64% of the total share capital [4] - The largest shareholder is Litian Development Co., Ltd., holding 41.98% of the shares [4]
信隆健康(002105.SZ):2025年中报营业总收入为5.82亿元,实现2年连续上涨